Hi Rachel, Thanks for your comments. I think that this interdisciplinary distinction is overblown in general. Economists are catching up on some things with RCTs, like ex ante study protocol registrations, due to the fact that they had a late start. Public health/biomedical field has its shortcomings as well. But as we work with each other, these differences in approach are starting to blur. This space opposes statements unwarranted by the data regardless of the disciplinary background of the source. We hope that posts over two years provides some evidence of that. Sincerely, Berk.